The Board of Directors of Piramal Pharma Limited has approved the appointment of Sai Ramana Ponugoti as Chief Executive Officer (CEO), India Consumer Healthcare (ICH) with effect from 6th January, 2025.

Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.

Ponugoti brings over 20 years of diverse and exemplary leadership experience, gained through his tenure at Procter & Gamble (P&G), where he held several senior roles across India as well as markets across Asia-Middle East-Africa. As the current Chief Sales Officer for P&G India, he has successfully led constructive disruptions, contributing to significant business growth and profitability. In his previous role as the Country Manager for P&G Vietnam, he successfully managed a complex business environment to deliver superlative business and organization results.

Throughout his career, Ponugoti has been a champion of customer-centricity and innovation, consistently leading constructive disruptions and delivering superior business results, including successful profit transformation. His strategic vision, focus on balanced growth, and ability to build world-class organizations have been key to his success. Additionally, his deep passion for talent development and a commitment to fostering a culture of equality and inclusion have played a pivotal role in shaping high-performing teams.

Ponugoti holds an MBA from the Indian Institute of Management, Lucknow. He will leverage his extensive experience to drive accelerated growth and expansion of the company’s health and wellness portfolio, which encompasses over 25 trusted consumer brands and to make a positive difference by delivering innovative solutions that serve consumers and bring to life Piramal Pharma’s purpose of ‘Doing well and Doing good’.